AB-CHMINACA


AB-CHMINACA is an indazole-based synthetic cannabinoid. It acts as a potent agonist for the cannabinoid receptors which produces subjective effects somewhat similar to that of cannabis. It was developed by Pfizer and disclosed in a 2009 patent as a potential analgesic medication, but was never pursued for human use.

psychonautwiki

The physiological and toxicological properties of this compound are not known. This product is intended for forensic and research applications.

 

product details

 

Category:

Description

AB-CHMINACA is an indazole-based synthetic cannabinoid. It acts as a potent agonist for the cannabinoid receptors which produces subjective effects somewhat similar to that of cannabis. It was developed by Pfizer and disclosed in a 2009 patent as a potential analgesic medication, but was never pursued for human use.

psychonautwiki

The physiological and toxicological properties of this compound are not known. This product is intended for forensic and research applications.

TYPE: Cannabinoid

POWER: light | normal | strong | very strong

Systematic (IUPAC) name: N-[(2S)-1-Amino-3-methyl-1-oxobutan-2-yl]-1-(cyclohexylmethyl)indazole-3-carboxamide
CAS Number: 1185887-21-1
PubChem: 44206133
ChemSpider: 30646774
UNII: QG3J28E7L8
Formula: C20H28N4O2
Molar mass: 356.46 g/mol

Reviews

There are no reviews yet.

Be the first to review “AB-CHMINACA”
feedback_mix.png